tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ling Wang, 34 are a BUY (94.44%), 2 are a HOLD (5.56%).
Analyst Ling Wang, carries an average stock price target met ratio of 41.36% that have a potential upside of 42.41% achieved within 444 days. Previously, Ling Wang worked at OPPENHEIMER.
Ling Wang’s has documented 76 price targets and ratings displayed on 11 stocks. The coverage was on Healthcare, Technology sectors.
Most recent stock forecast was given on DQ, Daqo New Energy Corp ADR at 24-Sep-2021.
Analyst best performing recommendations are on LJPC (LA JOLLA PHARMACEUTICAL CO).
The best stock recommendation documented was for LJPC (LA JOLLA PHARMACEUTICAL CO) at 4/20/2015. The price target of $43 was fulfilled within 141 days with a profit of $23.93 (125.49%) receiving and performance score of 8.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$24
$-7.23 (-23.15%)
$6
1 years 11 months ago
(30-Nov-2023)
5/6 (83.33%)
$-5.32 (-18.14%)
721
Hold
$25
$-6.23 (-19.95%)
1 years 11 months ago
(30-Nov-2023)
3/4 (75%)
$-4.32 (-14.73%)
676
Hold
$31
$-0.23 (-0.74%)
$12
1 years 11 months ago
(30-Nov-2023)
2/2 (100%)
$1.68 (5.73%)
294
Hold
$31
$-0.23 (-0.74%)
$26
1 years 11 months ago
(30-Nov-2023)
3/3 (100%)
$1.68 (5.73%)
136
Hold
$27
1 years 11 months ago
(30-Nov-2023)
4/4 (100%)
$9.83 (57.25%)
134
What Year was the first public recommendation made by Ling Wang?
